A+ A A-

Download article


Myslivets M.G., Paramonova N.S., Smirnov V.Y.
Determining the risk of juvenile rheumatoid arthritis development in patients with the articular syndrome
Grodno State Medical University, Grodno, Republic of Belarus

Vestnik VGMU. 2019;18(2):60-66.

Objectives. To develop a model for determining the risk of juvenile rheumatoid arthritis (JRA) development in patients with the articular syndrome.
Material and methods. 80 patients with the articular syndrome were examined. Among them there were 47 patients with juvenile rheumatoid arthritis, 33 children with arthritis, non-associated with autoimmune pathology. Clinical data, C-reactive protein (CRP) indices, those of seromucoid, the number of leukocytes, alkaline phosphatase levels were assessed. The method of high performance liquid chromatography was used to determine the level of homocysteine and sulfur-containing amino acids in the blood serum. The level of 25(OH)D in the blood serum was estimated by ELISA test. In order to identify the signs that influence the development of juvenile rheumatoid arthritis in patients with the articular syndrome the regression analysis with the construction of a mathematical equation was made. ROC analysis was conducted for assessment of the received model quality.
Results. Distinctions of the studied indicators among patients of both groups were revealed. The values are statistically significant, (р<0.05). According to the results of the regression analysis the mathematical model with the sensitivity of 83.3%, specificity of 92.1% was developed. It helps to evaluate the risk of juvenile rheumatoid arthritis development in patients having the articular syndrome with the diagnostic effectiveness 87.0%.
Key words: children, joints, juvenile rheumatoid arthritis, diagnosing, regression analysis, risk of development.


1. Nasonov EL, Nasonova VA, red. Rheumatology. National leadership. Moscow, RF: GEOTAR-Media; 2010. 720 р. (In Russ.)
2. Bellucci E, Terenzi R, La Paglia GM, Gentileschi S, Tripoli A, Tani C, Alunno A. One year in review 2016: pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol. 2016 Sep-Oct;34(5):793-801.
3. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011 Dec 8;365(23):2205-19. doi:
4. Consolaro A, Ruperto N, Bazso A, Pistorio A, Magni-Manzoni S, Filocamo G, et al. Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum. 2009 May;61(5):658-66. doi:
5. Horneff G, Becker I. Definition of improvement in juvenile idiopathic arthritis using the juvenile arthritis disease activity score. Rheumatology (Oxford). 2014 Jul;53(7):1229-34. doi:
6. Consolaro A, Negro G, Chiara Gallo M, Bracciolini G, Ferrari C, Schiappapietra B, et al. Defining criteria for disease activity states in non-systemic juvenile idiopathic arthritis based on a three-variable Juvenile Arthritis Disease Activity Score. Arthritis Care Res (Hoboken). 2014 Nov;66(11):1703-9. doi:
7. Ringold S, Ward TM, Wallace CA. Disease activity and fatigue in juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2013 Mar;65(3):391-7. doi:
8. Hahn YS, Kim JG. Pathogenesis and clinical manifestations of juvenile rheumatoid arthritis. Korean J Pediatr. 2010 Nov;53(11):921-30. doi:
9. Das D, Bhattacharya I, Saxena R, Saxena R, Lal AM. Relationship between Uric Acid and Ascorbic Acid in Rheumatoid Arthritis Patients. Sch J App Med Sci. 2014;2(5C):1711-4.
10. Cohran VC, Griffiths M, Heubi JE. Bone Mineral Density in Children Exposed to Chronic Glucocorticoid Therapy. Clin Pediatr (Phila). 2008 Jun;47(5):469-75. doi:
11. Kostik MM, Larionova VI, Shcheplyagina LA. Clinical predictors of low bone mineral density in children with juvenile idiopathic arthritis. Osteoporoz Osteopatii. 2014;(2):11-5. (In Russ.)
12. Stagi S, Bertini F, Cavalli L, Matucci-Cerinic M, Brandi ML, Falcini F. Determinants of vitamin D level in children, adolescents, and young adults with juvenile idiopathic arthritis. J Rheumatol. 2014 Sep;41(9):1884-92. doi:
13. Di Rosa M, Malaguarnera M, Nicoletti F, Malaguarnera L. Vitamin D3: a helpful immunomodulator. Immunology. 2011 Oct;134(2):123-39. doi:
14. Lee YH, Bae SC. Vitamin D level in rheumatoid arthritis and its correlation with the disease activity: a meta-analysis. Clin Exp Rheumatol. 2016 Sep-Oct;34(5):827-833.
15. Pelajo CF, Lopez-Benitez JM, Miller LC. 25-hydroxyvitamin D levels and vitamin D deficiency in children with rheumatologic disorders and controls. J Rheumatol. 2011 Sep;38(9):2000-4. doi:

Information about authors:
Myslivets M.G. – lecturer of the Chair of Childhood Diseases No.2, Grodno State Medical University;
Paramonova N.S. – Doctor of Medical Sciences, professor, head of the Chair of Childhood Diseases No. 2, Grodno State Medical University;
Smirnov V.Y. – Candidate of Biological Sciences, senior research officer of the Scientific-Research Laboratory, Grodno State Medical University.

Correspondence address: Republic of Belarus, 230009, Grodno, 80, Gorky str., Grodno State Medical University, Chair of Childhood Diseases No.2. E-mail: Этот адрес электронной почты защищён от спам-ботов. У вас должен быть включен JavaScript для просмотра. – Marina G. Myslivets.

Поиск по сайту